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ABSTRACT
Comparative genomic hybridization by means of BAC
microarrays (array CGH) allows high-resolution pro-
filing of copy-number aberrations in tumor DNA.
However, specific genetic lesions associated with
small but clinically relevant tumor areas may pass
undetected due to intra-tumor heterogeneity and/or
the presence of contaminating normal cells. Here,
we show that the combination of laser capture micro-
dissection, f29 DNA polymerase-mediated isother-
mal genomic DNA amplification, and array CGH
allows genomic profiling of very limited numbers of
cells. Moreover, by means of simple statistical mod-
els, we were able to bypass the exclusion of amplifica-
tion distortions and variability prone areas, and to
detect tumor-specific chromosomal gains and losses.
We applied this new combined experimental and ana-
lytical approach to the genomic profiling of colorectal
adenomatous polyps and demonstrated our ability to
accurately detect single copy gains and losses affect-
ing either whole chromosomes or small genomic
regions from as little as 2 ng of DNA or 1000 micro-
dissected cells.
INTRODUCTION
Chromosomal instability (CIN) plays a central role in the
progression and malignant transformation of solid tumors
(1–3). However, evaluation of genome-wide CIN is often
hampered by technical and sample limitations. Tumor cyto-
genetics is often not feasible even from freshly isolated tumors
and requires short-term culturing of parenchymal cells. More-
over, different areas within a tumor may show heterogeneous
CIN patterns associated with different malignant potentials.
Also, tumor specimens are invariably contaminated with
varying amounts of surrounding and/or infiltrating normal
cells interfering with the analysis. Thus, a method is
ideally required that enables the detection of chromosomal
aberrations in small numbers of microdissected tumor cells
(4,5). Such a method should also be sufficiently sensitive to
detect single copy gains and losses, the most frequent genomic
alterations in most tumor types (6).
Comparative genomic hybridization (CGH) by means of
microarrays containing large-insert genomic clones such as
bacterial artificial chromosomes (BACs) provides a sensitive
and quantitative approach to assess DNA copy-number aber-
rations in tissue samples (6–8). Classical array CGH
requires hundreds of nanograms of genomic DNA for fluor-
escent labeling, a prohibitive amount when working with
microdissected samples. Several methods to amplify total
genomic DNA have been applied to array CGH, most of
them based on thermocycling protocols, such as degenerate
oligonucleotide-primed (DOP) PCR (9) and ligation-
mediated (LM) PCR (10). These methods produce relatively
low molecular weight DNA that may not be representative
of the entire genome (11). In contrast, multiple strand
displacement amplification (MDA) generates thousands of
high-molecular weight copies of genomic DNA in a robust
simple protocol without the use of thermocycling or ligation
of DNA adaptors (12,13). This amplification mechanism
favors equal representation of sequences because each prim-
ing event is propagated over very long distances in the
genome. Array CGH with MDA amplified DNA performs
comparable to unamplified array CGH (14), and allows reli-
able detection of high-level copy-number changes (gene-
dosage alterations of 3-fold or more) on cDNA microarrays
(15) and synthetic oligonucleotide arrays (16). We aimed at
significantly improving this method to allow reliable detec-
tion of low-range alterations and apply it to microdissected
neoplastic lesions.
We developed an experimental approach combining laser
capture microdissection (LCM), isothermal genomic DNA
amplification and array CGH on BAC microarrays, which
have a better signal-to-noise ratio compared to cDNA micro-
arrays. To validate the method, we have generated a series
of amplified CGH profiles from normal female and male
DNA, and from cell lines with known gains on chromosome
X or 20. Using two simple statistical methods, we were able
to avoid the exclusion of genomic regions affected by
*To whom correspondence should be addressed at Center for Human and Clinical Genetics, Leiden University Medical Center, Wassenaarseweg 72, 2333 AL
Leiden, The Netherlands. Tel: +31 71 527 6611; Fax: +31 71 527 6075; Email: j.m.boer@lumc.nl
Nucleic Acids Research, Vol. 32 No. 19 ª Oxford University Press 2004; all rights reserved
Nucleic Acids Research, 2004, Vol. 32, No. 19 e146
doi:10.1093/nar/gnh142
 Published online October 28, 2004
amplification distortions and high variability, and to detect
single copy changes varying in length from a few clones to
a whole chromosome. Finally, we applied the combined
experimental and statistical approach to the analysis of
microdissected dysplastic cells from colorectal adenomatous
polyps derived from patients affected by familial adenoma-
tous polyposis (FAP), an autosomal dominant genetic
predisposition to the development of hundreds to thousands
benign adenomas in the distal gastro-intestinal tract, caused
by germline mutations in the APC gene on chromosome 5q
(17). We demonstrate the sensitivity of our LCM-CGH array
approach by the detection of a small 5q deletion subse-
quently validated by PCR-based loss-of-heterozygosity
(LOH) analysis. These results underline the usefulness of
our approach in the study of chromosomal imbalances in
small subpopulations of microdissected tumor cells or in
other cases where limited amounts of DNA are available.
MATERIALS AND METHODS
Genomic clone library and generation of array probes
The human 3600 BAC/PAC genomic clone set, covering the
full genome at 1 Mb-spacing used for the production of our
arrays was obtained from the Welcome Trust Sanger Institute
(http://www.sanger.ac.uk/). Information on this clone set
can be obtained at the BAC/PAC Resources Center Web
Site (http://bacpac.chori.org). Degenerated oligonucleotide
PCR-products were prepared for spotting on CodeLink1
slides (Amersham Biosciences) according to detailed proto-
cols (5) with some modifications (18).
DNA samples for array CGH
The data set comprised the measurements from 17 independ-
ent array CGH experiments. Normal male and female DNA
samples used as controls and as reference in the hybridization
were obtained from a commercial source and consisted of
pools of individuals (Promega). The genomic DNA from
5cl20 sample was selected for testing, since it contained a
known trisomy over five clones on chromosome 20 (position
12639830 to 16682277 Mb at 20p12.1). The lymphoblastoid
cell line used contains a known X trisomy. Normal epithelial
(D5_14) and dysplastic adenoma (D5_1) cells were micro-
dissected from human colon tissue specimens from a male
individual affected by FAP. Three normal mucosa samples
were microdissected from healthy control individuals, one
male (NC1) and two females (NC2 and NC3). The frozen
colon specimens used for microdissection were collected in
Tissue-Tec1 (Sakura) embedding medium and snap-
frozen in 2-methylbutane (Sigma) and dry ice. Tissue sections
(10 mm) were sliced with a Shandon Cryotome1 Cryostat
(Shandon), and directly transferred to a UV-cross-linked
PEN membrane (P.A.L.M. Microlaser Technologies)
mounted on a PALM1 Membrane Slide (1 mm). Slides
with mounted sections were immersed immediately and stored
up to one week in 70% ethanol at 4C.
Microdissection and DNA extraction
Following the staining of the tissue sections with Mayer’s
Hematoxilin and Eosin Y solutions, 1000 parenchymal cells
(600 000 mm2) were microdissected and laser pressure cata-
pulted using the PALM1 MicroBeam microscope system
(P.A.L.M. Microlaser Technologies). The genomic DNA
was extracted using the protocol from Isola et al. (19), adapted
to small DNA amounts. Briefly, the adaptations included the
resuspension of the microdissected cells in 100 ml of DNA
extraction buffer, an overnight digestion with 0.6 mg/ml of
proteinase K and a replacement of glycogen by 10 mg of
GenEluteTM linear polyacrylamide (Sigma) in the precipita-
tion step. All samples were resuspended in 10 ml of TE buffer
(10 mM Tris–HCl pH 7.4, 0.1 mM EDTA). Tests performed
with DNA amounts that could be assessed on conventional
agarose gels indicated that the average size of genomic DNA
purified using this procedure was >20 kb.
GenomiPhi amplification and purification
A volume of 1 ml out of 2 ng/ml dilutions from cell lines and
control DNA samples and from all microdissected samples
(concentrated by speedvac from 8 ml) was used as starting
material for the amplification. The f29-amplification was
carried out according to the GenomiPhi kit manufacturer’s
instructions (Amersham Biosciences), using an incubation
time of 16 h. GenomiPhi reactions were checked on a 0.6%
agarose gel. An amplification was considered successful when
a smear of DNA fragments, ranging from 1 to 20 kb, was
visible. Samples were purified using Microcon1 YM-100
spin columns (Millipore) according to the manufacturer’s
protocol and concentrated to 25 ml in water.
TH01 diagnostic PCR
In order to roughly access the amount of DNA isolated from
microdissected samples, we have used a PCR, specific for
the TH01 human marker (20). Each 2 ml of microdissected
sample was compared to 1 ml of serial dilutions of female and
male control DNAs (10, 5, 2, 1, 0.5, 0.1, 0.01, 0.001 ng/ml).
The 25 ml reactions contained 1X GeneAmp1 PCR Buffer
(Applied Biosystems), 1.5 mM MgCl2, 0.2 mM dNTPs Mix,
500 nM oligonucleotides TH01-1 (forward: 50-GTGGGCTG-
AAAAGCTCCCGATTAT-30) and TH01-2 (reverse: 50-
ATTCAAAGGGTATCTGGGCTCTGG-30) and 1 unit of
AmpliTaq1 DNA Polymerase (Applied Biosystems). The
cycling conditions were as follows: 1 min at 94C; 35 cycles
of 20 s at 94C, 20 s at 55C and 20 s at 72C; 10 min at 72C
and then held at 25C. TH01 amplification products (–200 bp)
were checked on a 2% agarose gel or on a Bioanalyzer
2100 (Agilent) using a DNA 1000 LabChip kit, according
to manufacturer’s instructions. Due to a frequently observed
background synthesis in the GenomiPhi amplified water con-
trol, the above-described PCR methodology was routinely
used as an extra quality control on 1 ml (1/50 dilution) of
unpurified f29-amplified DNA. The TH01 specific band
should be present in all GenomiPhi amplified samples and
absent from the GenomiPhi water control.
Labeling and hybridization
By default, Cy3 and Cy5 fluorescent channels were used to
label test and reference DNA, respectively, except when
otherwise specified. The labeling and hybridization protocols
described by Fiegler et al. (5) were used, with some modi-
fications in the labeling. Briefly, 130.5 ml of solution
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containing 5 ml of f29-amplified or 450 ng of unamplified
DNA, 60 ml of BioPrime1 DNA Labeling System random
primers solution (Invitrogen) and water was incubated for
10 min at 100C, and subsequently cooled on ice. After the
addition of 15 ml of 10· dNTPs labeling mix (1 mM dCTP,
2 mM dATP, 2 mM dGTP and 2 mM dTTP), 1.5 ml of
1 mM Cy3- or Cy5-dCTP (Amersham Biosciences) and 120 U
of BioPrime1 DNA Labeling System Klenow fragment
(Invitrogen), the mixture was gently mixed and subsequently
incubated overnight at 37C. The addition of 15 ml of
BioPrime1 DNA Labeling System Stop Buffer (Invitrogen)
ended the reaction. In one tube, Cy3-labeled sample and
Cy5-labeled reference DNAs were mixed together, and
135 mg of human Cot-1 (Roche), 55 ml of 3 M sodium
acetate (pH 5.2) and 1 ml of cold 100% ethanol were
added. In a second tube, 80 mg of denatured herring
sperm DNA (Sigma) was mixed with 135 mg of human
Cot-1 (Roche), 23 ml of 3 M sodium acetate (pH 5.2)
and 400 ml of cold 100% ethanol. After gentle mixing
of the two labeling mixes, the labeled nucleic acids were
precipitated overnight at 20C. Hybridizations were
performed as described in (5). Sixteen-bit fluorescent images
were acquired with a DNA Microarray Scanner (Agilent)
and the resulting TIFF images were analyzed with
the GenePix Pro 4.0 software (Axon Instruments). Per
array, a GenePix results file (.gpr) with the extracted Cy3
and Cy5 spot and background raw intensities was generated.
Computational and statistical analysis
Data analysis was performed with a set of functions imple-
mented in R (21) (http://www.r-project.org/). Briefly, gpr files
were directly loaded into the R environment using the
marrayTools package. Intensity data were normalized with
the local robust regression function Lowess contained in
the package marrayNorm. The resulting log2 Cy3/Cy5
transformed ratios from each set of triplicate spots were
subsequently averaged to produce a unique ratio for each
BAC clone. After this step, spots designated as empty,
blank and Cy-dye controls, and spots with uncertain chromo-
some locations (clone id >35650 in the data set) were removed.
The final data set, used in subsequent analysis, consisted of
3615 independent observations per sample. For all experi-
ments, data was organized per chromosome and the clones
were ordered from chromosome 1 to chromosome Y according
to their Golden Path Mb position (http://genome.ucsc.edu/).
Although data from all chromosomes was analyzed, for illus-
tration purposes of the methods, the data from chromosomes 5,
20, X and Y only are shown. The data were analyzed sepa-
rately per chromosome, given that chromosomes are not
directly related and some display more variability than others.
Histograms of the normalized log2 clone-specific associated
residuals were also produced and they indicated that the error
measurements approximately follow a normal distribution.
Linear regression model. The explanatory factors of interest
are Fx and Fy, which are qualitative variables with levels (k)
defined by the columns Fx and Fy level (Table 1). For any
given chromosome with n clones, the model used for the copy-
number ratios, observed for the level k of the factor under
study and clone j, Yjk was
Yjk = m + ak + bj + ejk, 1
where ak and bj represent the factor-specific and clone-specific
effect respectively, m is the intercept (level 0, no change) based
on the two normal male versus male comparisons (CGH3_2
and 4), and ejk is the error with mean zero and constant var-
iance. The term bj in the model takes care of individual clones
varying technical performances. The model in Equation 1
was first fitted to X chromosome clones from the pilot and
microdissected subsets (Table 1) and subsequently, the same
approach was used for the remaining chromosomes. Finally,
we extracted the P-values for the factor under study from the
ANOVA table for the fitting of the model in Equation 1. These
P-values were not used as probabilities but merely to compare
model fits for different chromosomes. Factor effects plots were
drawn with the qvcalc R package. Comparable error bars were
computed using, instead of the computed variances, quasi-
variances (22), which consists of variances adjusted for the
covariance structure.
Table 1. Experimental data sets
Array Sample (Cy3) Known chromosome
rearrangements
Ref a (Cy5) X chromosome
Expected ratios Fx level
Y chromosome
Expected ratios Fy level
Amplified pilot subset
CGH3_1 XXa — XY 2:1 1 0:1 1
CGH3_3 XXa — XY 2:1 1 0:1 1
CGH4_74 XXX X XX 3:2 +0.5 0:0 0
CGH4_75 XXX+XXb X XX 2.5:2 +0.25 0:0 0
CGH4_73 5cl20, XY gain 5 cl 20p12.1 XY 1:1 0 1:1 0
CGH3_2 XYa — XY 1:1 0 1:1 0
CGH3_4 XYa — XY 1:1 0 1:1 0
CGH5_26 XY+XXb — XX 1.5:2 0.25 0.5:0 +0.5
CGH5_27 XYa — XX 1:2 0.5 1:0 +1
Amplified microdissected samples subset
CGH4_59 NC1, XY — XY 1:1 3 1:1 0
CGH4_60 NC2, XX — XY 2:1 4 0:1 1
CGH4_61 NC3, XX — XY 2:1 5 0:1 1
CGH3_23 D5_1, XY ? XY 1:1 6 1:1 0
CGH3_40 D5_14, XY — XY 1:1 7 1:1 0
aCommercial DNA pools.
bMixture of equal amounts.
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Non-parametric Smith–Waterman dynamic algorithm. To
detect gains and deletions over a few neighboring clones and
simultaneously test their statistical significance against a refer-
ence baseline, we used the Smith–Waterman analytical
algorithm (23), implemented in R (24) (http://www.well.ox.
ac.uk/~tprice/). The algorithm was first applied to chromosome
20 data from sample 5cl20, to compare its clone ratios to
each clone ratio median from the remaining eight samples,
using a d threshold of 3.6. The same algorithm was applied to
chromosome 20 and to the other chromosomes data from the
remaining samples from the pilot and microdissected data
(Table 1).
Loss-of-heterozygosity analysis of 5q dinucleotide
repeats
LOH in 5q21.1–5q31.1 was analyzed by amplification of the
dinucleotide repeat markers D5S400 (distal), D5S409 (LOH
region) and D5S427 (proximal). The localization and the
primer sequence of the markers were obtained from the
ENSEMBL project (http://www.ensembl.org). Allele sizes
were obtained from The Genome Database of the Human
Genome Project (http://www.gdb.org). A radioactive PCR was
performed using 1 ml of a 1:10 dilution of f29-amplified tumor
and normal mucosa DNA from patient D5. An aliquot of
100 ng of unamplified DNA isolated from ethanol-fixed
normal intestinal mucosa from the same patient was used as
additional control. Amplifications were carried out in a 10 ml
volume, containing 10 mM Tris–HCl, pH 8.9, 50 mM KCl,
2.5 MgCl2, 10% glycerol, 200 mg/ml BSA, 0.01% gelatin,
0.2 mM of each dATP, dGTP and dTTP, 0.05 mM dCTP,
0.25 mCi of dCTP (3000 Ci/mmol), 0.2 U Taq polymerase
and 10 pmol of each primer (25). The cycling conditions
were as follows: 1 cycle at 94C for 4 min, followed by
35 cycles at 94C for 1 min, 55C for 1 min, 72C for
1 min and final cycle at 72C for 6 min. The amplified frag-
ments were resolved in a denaturing 6% polyacrylamide gel
and dried on paper, and subsequently scanned on a Typhoon
9200 imager (Amersham Biosciences). The generated TIFF
images were subsequently analyzed with ImageQuant v5.21
software (Amersham Biosciences). The allelic imbalance was
calculated as described elsewhere (26). LOH is interpreted as
significant when the calculated comparative allelic ratio
values are >1.5 (loss of the smaller allele) or <0.6 (loss of
the larger allele).
Genomic microarray data
The genomic microarray data discussed in this publication
have been deposited in NCBIs Gene Expression Omnibus
(GEO; http://www.ncbi.nlm.nih.gov/geo/) and are accessible
through GEO Series accession number GSE1841.
RESULTS
Comparative genomic hybridization arrays: quality
controls
For this study, we have generated CGH microarrays covering
the full human genome by employing the human 3600
BAC/PAC genomic clone set from the Welcome Trust Sanger
Institute. Individual BAC clones were amplified by degener-
ated oligonucleotides and the PCR-products spotted on glass
slides (see Materials and Methods). The specificity and sensi-
tivity of our genome-wide 1 Mb-spaced CGH microarray was
tested with a series of control hybridizations using unamplified
DNA samples (Figure 1A and B). Assuming that a chromo-
somal region is classified as amplified or deleted when clone
ratios fall outside fixed thresholds (+0.26 and 0.26 in log2
scale) for copy-number gain or loss respectively (27–30); for
both arrays, >99% of the autosomal BAC clone ratios are
contained within these limits (0 – 0.07). Similar results are
obtained for the log2 ratios of clones on the X chromosome
(0 – 0.11) and Y chromosome (0 – 0.09) in the male versus
male comparison (Figure 1A), while the female versus male
comparison resulted in log2 ratios of 0.63 – 0.22 for X-derived
and 1.66 – 1.05 for Y-derived BAC clones (Figure 1B).
These results are concordant with the overall results expected
for CGH profiling using unamplified control samples (6,8),
certifying the quality of our arrays. The log2 ratios observed
for X and Y in the female versus male hybridization are
smaller than expected for the gene copy differences. This
‘dynamic range compression’ is commonly observed with
array CGH, both for unamplified and amplified samples (6,8).
Linear amplification of genomic DNA
Classical array CGH requires genomic DNA in amounts well
above those obtained by LCM tissues. To overcome the
problem of limited amounts of starting material, the f29
polymerase was used to linearly amplify high-molecular
weight genomic DNA and LCM-derived templates. It was
expected that f29 polymerase-mediated reactions using
small amounts of template would reach high amplification
yields (12,15). However, in addition to high amplification
yields, f29-mediated reactions also resulted in the generation
of aspecific products both in the presence of non-human DNA
(l genomic DNA) and even when no DNA template was
employed (Supplementary Figure A). Apparently, f29 is
capable of primer-directed DNA synthesis in the absence of
template via a yet unknown mechanism (15,31). To control for
human-specific DNA synthesis, we employed conventional
PCR on the f29-products to amplify the single-copy
human marker TH01 (20). As expected, the 200 bp TH01-
specific product was observed exclusively when human
DNA templates were employed (Supplementary Figure B).
Figure 1. Reproducibility of f29-amplified array CGH. (A–D) Comparison of classical array CGH with f29-amplified array CGH. Normalized copy-number ratios
of genomic DNA samples from 5cl20 male, unamplified (A) and f29-amplified (C), and a control female DNA pool, unamplified (B) and f29-amplified (D). All
samples were compared with an unamplified male reference DNA pool. Data are plotted as the mean log2 ratio of the triplicate spots for each clone after Lowess
normalization. The BACs are ordered by position in the genome beginning at 1p and ending at Yq. Borders between chromosomes are indicated by vertical bars, the
horizontal solid line indicates a log2 ratio of 0 (no change), and the horizontal dashed lines indicate the +/ 0.26 confidence limits for copy-number gain or loss,
respectively. The trisomic region in sample 5cl20 on chromosome 5 is indicated by an arrow in (A). (E–H), co-plotting of sample versus reference array CGH ratios
(green) with an ‘average’ amplified normal CGH profile (red; see text), shows the non-random behavior of the f29-induced effect on the copy-number ratios.
Amplified array CGH patterns from the diluted DNA samples 5cl20 male (E) and female control (F) are comparable to those of two normal mucosa DNA samples
isolated after microdissection, NC1 male (G) and NC2 female (H).
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Due to the fact that the aspecific amplification contributes to
the amount of amplified DNA, conventional DNA quantifica-
tion methods such as spectrophotometry could not be used.
Therefore, we also used the TH01 PCR to semi-quantify the
amount of f29-amplified DNA to be used as input for
the labeling reaction. Finally, the TH01 PCR assisted us in
the estimation of LCM-derived genomic DNA amounts used
as input for the amplification reaction (Supplementary Figure C).
The comparison of TH01 amplification products generated
from serial dilutions of genomic DNA controls with TH01
amplification products generated using genomic DNA
obtained from 1000 microdissected colon epithelial cells
showed that the microdissection procedure on a tissue section
corresponding to an area of approximately 600 000 mm2
yielded 5–10 ng of genomic DNA. The f29 reaction yielded
approximately 1250–6250 ng of amplified DNA from 5 to
10 ng of starting DNA.
Reproducibility of amplification
To test the reproducibility of the f29 amplification reaction,
we co-hybridized f29-amplified female and male control
DNA samples against an unamplified male reference. Apart
from the expected overall increase in background noise, a
marked and reproducible ratio distortion is observed at specific
chromosomal regions (Figure 1C and D). Major affected
regions include 1p, and several telomeres (e.g. 7q and 8p)
and centromeres, known to be prone to ratio distortions due
to the repetitive nature of their sequences (32). The reprodu-
cible change in ratio structure becomes evident when replicate
normal versus normal hybridizations are compared. The
Pearson correlation between the autosomal log2 ratios
obtained in two amplified normal female versus male experi-
ments (Table 1, #1, 3) was high (0.90). In addition, we com-
pared the CGH profiles of each individual sample to an
‘average’ of amplified normal CGH profiles (Figure 1E and F;
for boxplots of individual BAC clones per chromosome see
Supplementary Material). The average normal profile is
calculated for autosomal clones as the mean intensity values
obtained from pilot subset samples (Table 1) with the exclu-
sion of 5cl20; for X- and Y-specific chromosomal regions, the
mean intensity values were calculated from three male sam-
ples included in the pilot subset (Table 1, #2, 4, 27). The
reproducible wave-like pattern of the ratio distortions is likely
to result from variability in the amplification process when
repetitive and polymorphic genomic regions are differentially
processed by the f29 polymerase (15). Accordingly, no
significant ratio distortion was observed when two normal
genomic DNA samples were separately microdissected
from the same sections, f29 amplified and co-hybridized
on the same array (Supplementary Figure D). The estimated
mean log2 ratios were comparable to those previously
observed with unamplified control DNA samples. Further-
more, we compared the ratio variability of f29-amplified
samples co-hybridized with an unamplified or an amplified
reference DNA and found no apparent difference (Supplemen-
tary Figure E). By including clone-specific characteristics such
as median log2 ratio and variability in our downstream statis-
tical analyses, we were able to analyze the amplified array
CGH profiles without excluding variability-prone clones
or regions.
In order to evaluate the quality of f29-amplified genomic
DNA from microdissected cells, we compared the CGH
profiles of f29-amplified diluted normal genomic DNA sam-
ples (Figure 1E and F) with the profiles from f29-amplified
DNA obtained from microdissected normal epithelial cells
(Figure 1G and H). Since these DNA profiles were com-
parable, the quality of the LCM-derived amplified DNA
apparently was not compromised by the microdissection
procedure. Therefore, we conclude that genomic DNA sam-
ples derived from laser capture microdissection and amplified
by f29 are suitable for array CGH profiling.
Statistical analysis of copy-number changes
To determine the sensitivity of our amplified array CGH
approach in detecting low levels of chromosomal gains and
losses, we generated a set of array CGH profiles with DNA
samples from cell lines ranging in the number of X and Y
chromosomes (Table 1). Since in our experience, ratio distor-
tions introduced by f29-mediated amplification are system-
atic, we set to implement an applied and validated statistical
model to deal with the variation and signify copy-number
changes. Employing chromosome X as a model, we assessed
the sensitivity of the CGH array technology in accurately
quantifying chromosome-wide changes on f29-amplified
DNA. Using our pilot data set encompassing different chro-
mosome X copy numbers (Table 1), we modeled six different
gain or loss scenarios: 2:1, 3:2, 1:1, 2.5:2 (gain of one copy in
50% of the cells), 1.5:2 (loss of one copy in 50% of the cells),
and 1:2. The observed log2 ratios for the X and Y chromo-
somes correlated with the expected chromosome dosage incre-
ments for the known karyotypes, while the log2 ratio for
autosomal clones was approximately 0 (Figure 2). The graphs
in Figure 2 also show that the variability of the measure-
ments increased proportionally to the chromosome X and Y
effect size.
For the detection of gains and losses of whole chromo-
somes, a linear regression model (see Materials and Methods)
was fitted separately per chromosome to all pilot subset sam-
ples, using as explanatory factor the class of expected ratios for
chromosome X (Fx). As expected, only when data from either
chromosomes X or Y was used, the tested variable Fx showed
a significant estimated difference compared to the baseline
level 0, indicating copy-number changes (Figure 3). Estimated
X chromosome ratios of 2:1, 3:2, 1.5:2 and 1:2 were highly
significant, as well as the more extreme Y chromosome ratios
of 0:1, 0.5:0 and 1:0 (significant values highlighted in bold in
Table 2). Similar to classical array CGH, the estimated ratios
were compressed compared to the expected ratios: an X chro-
mosomal gene dosage ratio of 2:1, with an expected log2 ratio
of 1 was measured as 0.8 difference to the intercept, 3:2
(log2 ratio 0.59) was measured as a difference to the intercept
of 0.35, 2.5:2 (log2 ratio 0.32) was measured as 0.06, 1.5:2
(log2 ratio 0.41) as 0.42 and 1:2 (log2 ratio 1) as 0.85.
Note, however, that this compression is linear (Figure 3C) and,
based on its estimate from the pilot subset samples, it can be
corrected. All Fx levels showed a significant estimated effect
difference from the intercept (level 0) except for the estimated
log2 ratio for 2.5:2 X chromosomes (Fx level 0.25, Table 1).
For this chromosome dosage level, the difference to the
intercept (0.06) was neither statistically nor biologically
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meaningful, indicating that the thresholds for the detection of
copy-number changes in f29-amplified genomic DNA are a
gain of one copy in all cells, and a loss of one copy in 50% of
the cells. Based on this pilot data set, we implemented a
threshold for biological relevance in addition to statistical
significance (P < 0.00001), requiring a log2 ratio compared
to the intercept larger than +0.35 or smaller than 0.35,
respectively for gain or loss.
Subchromosomal regions containing copy-number altera-
tions can be difficult to detect, especially when they overlap
with highly variable regions. We used the analytical Smith–
Waterman algorithm as modified by Karlin et al. (23,33),
implemented in R by Price et al. (24) (http://www.well.ox.
ac.uk/~tprice/1), to detect subchromosomal gains and losses in
our pilot CGH data (Figure 4A–C). After subtracting a user-
defined baseline threshold delta (d) to generate a negative
mean for each chromosome, the genome is scanned for
contiguous sequences of high positive or low negative scores,
which may indicate polysomic or monosomic regions, respec-
tively. High- or low-scoring segments of clones are denom-
inated as ‘islands’, when their scores cannot be increased by
shrinkage or expansion of the segment boundaries. The sta-
tistical significance of an island is estimated as the proportion
of times that a higher-scoring island is found in 1000 random
permutations of the coordinates of the scores, based on the
premise that successive scores from the permuted data approx-
imate the null distribution. The trisomic region present over
five clones on chromosome 20 from sample 5cl20 was cor-
rectly predicted with a d threshold of 3.6 (Figure 4B), with no
false-positive islands detected. Applying the same threshold to
chromosome 20 data from other samples (Figure 4A and C)
did not result in the detection of any significant islands
(p < 0.001). Also, chromosome 5 ratios (Figure 4D and E)
and ratios from the remaining chromosomes (data not shown)
were analyzed using the same approach and, as expected, no
significant copy-number alterations were detected.
Analysis of laser-capture microdissected epithelial cells
from human colon mucosa and adenomatous polyps
To obtain proof of principle for our combined LCM–array
CGH approach in the genomic profiling of human tissues,
the method was applied to f29-amplified DNA samples
derived from approximately 1000 microdissected human
colon cells. Three samples originated from control individuals,
one male (NC1) and two females (NC2 and NC3), and
two samples were derived from a male individual affected
by FAP, normal epithelium (D5_14) and dysplastic adenoma
cells (D5_1). Two illustrative normal CGH array profiles (NC1
and NC2) co-plotted with the average normal CGH profile
showed no autosomal genomic imbalances (Figure 1G and H).
Figure 2. Chromosome X and Y dosage effects in amplified array CGH. (A–I) Normalized array CGH ratios from nine f29-amplified control hybridizations with
varying dosages of X and Y chromosomes are plotted for four illustrative chromosomes (5, 20, X and Y). The genotypes for each sample and reference are given above
the plot, mixed DNA samples (1:1) are indicated by XX + XXX, etc. The horizontal red lines represent the expected X and Y chromosome ratios. An example of
reproducible under-representation of genomic sequences after amplification is visible for 20q telomeric BACs.
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We fitted the linear model using the Fx levels (Table 1) as
factor to these samples to detect whole chromosome
copy-number changes (Figure 3, right panel of each plot;
Table 2). Except for the sex chromosomes in sex-mismatched
hybridizations, none of the chromosomes from the microdis-
sected normal and patient samples showed statistically signif-
icant and biologically meaningful changes from the expected
number of two copies. Remarkably, the estimated X and Y
Figure3. Whole chromosome copy-number changesestimatedby linear regression. (A) Chromosome 5; (B) chromosome 20; (C) chromosomeX; (D) chromosome Y.
Estimated average copy-number log2 ratios from amplified array CGH hybridizations of control DNA samples 1–7 (left of vertical line in each plot) and
microdissected DNA samples 8–12 (right of vertical line in each plot) for illustrative chromosomes 5 (209 BACs), 20 (79 BACs), X (165 BACs) and Y (28
BACs). On the x-axis, the relative amounts of these chromosomes in the test and reference samples are indicated. 1–12 correspond to 1, XY:XX (CGH5_27); 2,
XY+XX:XX (CGH5_26); 3, XY:XY (CGH3_2) and XY:XY (CGH3_4)= intercept; 4, XXX+XX:XX (CGH4_75); 5, XXX:XX (CGH4_74); 6, XX:XY (CGH3_1)
and XX:XY (CGH3_3); 7, 5cl20 XY:XY (CGH4_73); 8, NC1:XY (CGH4_59); 9, NC2:XY (CGH4_60); 10, NC3:XY (CGH4_61); 11, D5_1:XY (CGH3_23); 12,
D5_14:XY (CGH3_40). On the y-axis are the log2 ratios estimated by the linear regression model for each Fx level compared to the intercept (level 0, no change;
horizontal solid line; note that the intercept may deviate from log2 ratio 0). The dashed horizontal lines mark the 95% confidence intervals, defined as the level 0 log2
mean estimated copy-number ratio –2 standard errors. The gray horizontal lines indicate the thresholds for a biologically meaningful copy-number change
(intercept – 0.35). Quasi-error bars (small vertical lines) associated with the estimated effects are only clearly visible for the Y chromosome, where the higher
variance is due to the lower number of BACs in the array. Given that the relationship between the estimated and the expected chromosome X values is linear (C), the
fitting of the linear regression model (Equation 1) on chromosome X data yielded the function E = 0.243 + 1.23R (R2 = 0.98), which describes the relationship
between R, the log2 ratio change estimates and E, their corresponding expected log2 ratio values.
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chromosome average log2 ratios in the female samples versus
male reference are lower than the corresponding estimated
ratios from diluted control DNA samples. We believe this might
be due to variations in the non-measurable low quantities of
LCM-derived DNA used as templates in f29 amplifications.
Co-plotting of the adenoma sample CGH ratios (D5_1) with
the average normal CGH profile (Figure 5A), suggested a loss
of genetic material in a subchromosomal region of
chromosome 5 that was not observed in the corresponding
normal tissue (Figure 5B). Consequently, using the Smith–
Waterman algorithm with a d threshold of 2.5, we detected
a sequence of 37 clones (36 Mb), deleted in the region
spanning from 5q21.1 to 5q31.1 (base position 100714436
to 135902806) encompassing the APC gene (5q22) causal
to FAP. Allelic imbalance at chromosome 5q was confirmed
by LOH analysis of dinucleotide repeat markers in the region
of interest. The comparative allelic ratio of marker D5S409
(<0.6), encompassed by the deletion, is indicative of loss of
heterozygosity at this locus (Figure 6). Markers D5S400 and
D5S427, mapping respectively distal and proximal to the dele-
tion predicted by array CGH, did not reveal allelic imbalances,
thus confirming the subchromosomal nature of the 5q deletion.
DISCUSSION
We present a robust, standardized protocol for the analysis of
genome copy-number alterations in DNA derived from as few
Figure 4. Detection of subchromosomal copy-number changes. Comparison off29-amplified array CGH data for two illustrative chromosomes, (A–C) 20 and (D–F)
5, analyzed with the Smith–Waterman algorithm to detect subchromosomal gains and deletions. Control male DNA (A and D), 5cl20 DNA (B and E) and
microdissected adenoma D5_1 DNA (C and F) were co-hybridized with an unamplified control male reference DNA (Table 1). Chromosomal position of the BAC
clones is indicated on the x-axis. The y-axis indicates the SW-scores associated with each clone, produced by subtracting a user-defined threshold delta (d) from the
Lowess normalized log2 ratios of the triplicate spots from each BAC clone. The vertical lines represent the Smith–Waterman algorithm partial sums S and the score of
the highest-scoring island (filled in gray) is given by its maximum height: chromosome 20 (d = 3.6) island in 5cl20 (B), score 0.98 (P = 0) and chromosome 5 (d = 2.5)
island in D5_1 (F), score 6.53 (P = 0.009).
Table 2. Regression-fitted estimated log2 ratios for chr 5, 20, X and Y
Expected ratios Arrays per level Chromosome 5 Chromosome 20 Chromosome X Chromosome Y
Est. P Est. P Est. P Est. P
Amplified pilot subset
XY:XY CGH3_2 CGH3_4 0 — 0 — 0 — 0 —
XX:XY CGH3_1 CGH3_3 0.02 0.09 0.06 0 0.80 <2e16 1.88 <2e16
XXX:XX CGH4_74 0.01 0.31 0.06 0.03 0.35 <2e16 0.29 0.1
XXX+XX:XX CGH4_75 0 0.85 0.02 0.53 0.06 1.1e2 0.25 0.2
XY+XX:XX CGH5_26 0.01 0.43 0.01 0.69 0.42 <2e16 1.35 1.5e12
XY:XX CGH5_27 0.03 0.01 0.03 0.34 0.85 <2e16 1.93 <2e16
XY(5cl20):XY CGH4_73 0.01 0.55 0.01 0.85 0.06 e2 0.05 0.74
ANOVA P-value 4e4 3e6 0 4.8e55
Amplified microdissected samples subset
XY:XY CGH4_59 0.01 0.29 0.07 0.01 0.07 0 0.04 0.82
XX:XY CGH4_60 0 0.81 0.07 0.01 0.39 <2e16 1 2e9
XX:XY CGH4_61 0 0.75 0.03 0.29 0.4 <2e16 0.96 9.3e9
XY:XY CGH3_23 0.13 <2e16 0.09 0.001 0.03 0.17 0 0.99
XY:XY CGH3_40 0.01 0.46 0.20 2e13 0.06 0.01 0.02 0.91
The Fx levels were compared to the intercept level 0, based on two control male versus male hybridizations (CGH3_2 and 4). Statistically (P < 0.00001) and
biologically significant (estimated log2 ratio <0.35 or > +0.35) values are highlighted in bold in the columns P and Est., respectively. All microdissected samples
were co-hybridized with male control reference DNA. Est., estimated log2 ratio; P, P-value.
PAGE 9 OF 13 Nucleic Acids Research, 2004, Vol. 32, No. 19 e146
as 1000 microdissected cells from histology specimens. The
f29 polymerase-based MDA generates high-molecular DNA
replication products in high yields, and is suitable when pro-
cessing large numbers of samples. Some representational
distortion occurs, which is likely to result from variability
in priming density and processing by the f29 polymerase of
repetitive and polymorphic sequences. Similar systematic
changes in copy-number structure were reported in other
array CGH studies using f29-amplified DNA (15,16). Some
amplification biases can be partially compensated for by using
test and reference samples amplified under the same condi-
tions (10,15,34–36). We compared the results of co-hybridiza-
tion of our test sample with amplified and unamplified
reference DNA samples, and surprisingly found similar ratio
distributions. Since previous studies used either a different
strand displacement polymerase (Bst) and cDNA microarrays
(15), or a PCR-based amplification method (10,34–36),
these results may not be directly comparable to ours.
Moreover, Lage et al. also successfully used an unamplified
reference sample in an evaluation experiment on human
BAC arrays (15). Taken the fact that the use of an
unamplified reference is simpler and less expensive for
high-throughput analyses of many samples, we opted for an
unamplified reference. As we show, the observed over- and
under-representations of specific genomic regions were repro-
ducible and as such can be handled with adequate statistical
tools. By taking individual clone-specific effects into account
in our statistical analyses, they were dealt with in an effective
way without excluding clones based on an arbitrary threshold.
This approach allowed us to analyze the whole genome,
including the Y chromosome, which is routinely excluded
entirely due to variable hybridization results, even in classical
array CGH (6,15,36).
Using the X chromosome as a model, we show that our
amplified array CGH method detects monosomy and trisomy
of the whole chromosomes using the linear regression model.
It was even possible to detect a loss of one copy in 50% of the
cells, while a similar sensitivity was not reached for a
single copy gain. The observed underestimation of the mag-
nitude of copy-number changes has been previously reported
in array CGH studies, and most likely results from incomplete
suppression of repetitive sequences or errors in background
subtraction (6,8). However, for all the analyzed X chromo-
some dosage levels, the relationship between the estimated and
the expected ratios were linear, indicating that the amplitude of
compression is constant over these levels. As the copy number
departed farther from the genome average, the variance of the
ratios measured for the X and Y chromosome clones increased.
These ratio variations were reproducible, suggesting that the
sequence characteristics of individual clones, possibly differ-
ing amounts of sequence shared between the X and Y chro-
mosomes, play a role (6). To establish a limit of accuracy for
small regions of gains or deletions, we applied amplified array
CGH to a sample known to harbor a trisomic region spanning
five BAC clones (5 Mb) on chromosome 20. This aber-
ration was readily detected using a simple, nonparametric
Smith–Waterman dynamic algorithm. The lack of assump-
tions in this method makes its use very convenient. For our
purpose, it demonstrated good sensitivity and specificity indi-
cating that the resolution of our amplified array CGH method
Figure 5. Amplified array CGH profiles from microdissected human colon cells. f29-amplified DNA profiles from 1000 microdissected cells (green), obtained (A)
from a low grade dysplastic area of a colorectal adenomatous polyp from a FAP patient (D5_1) and (B) from the corresponding histologically normal colorectal
mucosa (D5_14) plotted against an ‘average’ control DNA profile (red; see text). This co-plotting reveals the presence of a deletion on chromosome 5q in the adenoma
sample (arrow).
Figure 6. LOH analysis of microdissected adenoma and corresponding
normal mucosa at 5q. Three dinucleotide repeat markers mapped on
chromosome 5D5S400 (distal), D5S409 (deleted region) and D5S427
(proximal) were used on genomic DNA from the FAP patient D5. The
DNA samples were derived from non-microdissected, unamplified normal
mucosa (Nc), from microdissected, f29-amplified adenomatous tumor (T)
and from the corresponding microdissected, f29-amplified normal mucosa
(N). The gray horizontal line above chromosome 5 represents the 37 Mb
deletion. In the normal mucosa, the three loci show the expected two
alleles, but in the tumor sample one allele of D5S409 marker, internal to the
deletion is lost. The comparative allelic ratio (CAR) for this marker indicates
the loss of the larger allele (CAR < 0.6).
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is at least 5 Mb. Both statistical models have a very low false
discovery rate, when log2 ratio thresholds compared to the
intercept of 0.35 (0.78 in linear scale) and 0.35 (1.27 in
linear scale), representing a biologically meaningful gain or
loss, are applied in addition to a significant p-value. Our data
also show the importance of using a pilot study, with normal
and control samples carrying known copy-number changes.
The generated data can be subsequently used for calibration
and for sensitivity determination in the analytical approach.
Applying the novel LCM-array CGH protocol to the ana-
lysis of normal colon mucosa and colonic adenomatous polyps
from FAP patients provided proof of principle. A subchromo-
somal 5q deletion was detected by LCM-array CGH analysis
and confirmed by an independent PCR-based method.
Although we have not tested the minimum amount of input
DNA for the MDA reaction, the recommended minimal
amount is 1 ng, representing approximately 300–500 human
genomic equivalents.
As shown here, cryo-preserved tissues provide excellent
starting material for f29 amplification. However, the ampli-
fication efficiency is reduced proportionally to a decrease in
molecular weight of the starting material, which is problematic
for amplification of formalin-fixed archival DNA (15).
Recently, several other methods for whole-genome amplifica-
tion in combination with array CGH were described.
Balanced-PCR amplification (36) employs digestion and liga-
tion of a target and control genome with distinct linkers, which
are mixed and amplified in a single PCR, thereby avoiding
biases associated with PCR saturation and impurities. This
procedure showed equivalent performance compared to
MDA on cDNA microarrays using intact genomic DNA,
but overcomes problems associated with modest DNA de-
gradation in formalin-fixed paraffin-embedded tissues (36).
Guillaud-Bataille et al. present an optimized LM-PCR proto-
col using 1 ng of starting DNA and BAC arrays. This approach
preserves the initial ratios observed with BAC array CGH,
allowing the reliable detection of one-copy-level variations
among the amplified material (10). Although this method
has not yet been applied to microdissected samples, the results
on cell line DNA are very promising.
cDNA arrays typically consisting of several tens of thou-
sands of features are used for array CGH experiments because
of their more common availability and higher resolution
(15,36–38). Compared to BAC arrays, however, the signal-
to-noise ratio is lower and signals of two to five neighboring
clones are averaged to improve signal reproducibility. To
reach a similar resolution using BAC arrays, around
10 000–30 000 BACs would be necessary, resulting in a tiling
array for the human genome (39). Since the size of the BACs,
150–200 kb, ultimately obscures higher resolution, microar-
rays containing 25mer (38,40,41) or 60–70mer (42–44) oligo-
nucleotide probes are currently being explored for measuring
DNA copy-number changes. The commercially available syn-
thetic 25mer high-density oligonucleotide arrays, which were
originally designed to detect single-nucleotide polymorphisms
(SNPs) (45), have the advantage of giving genotyping data in
conjunction with copy-number analysis (38,40,41). Overall,
this platform exhibited more variability than BAC array-based
CGH, and while high-level amplifications and homozygous
deletions were reliably reported, changes resulting in loss or
gain of a single copy were often missed in unamplified tumor
cell line DNA (38,41). It is anticipated that as SNP density
increases, resolution and the ability to assess subtle copy-
number changes will increase. Importantly, in a small-scale
study, Wong et al. used SNP arrays in combination with f29-
amplified DNA from two tumor biopsies, and showed good
concordance between amplified and unamplified DNA for a
high-level amplification and deletion (40). This study shows
the feasibility of combining MDA whole-genome amplifica-
tion with sensitive copy-number analysis at high resolution.
In summary, we show that the strand displacement poly-
merase f29 reproducibly amplifies starting amounts of geno-
mic DNA as low as 2 ng or 1000 laser-capture microdissected
cells, resulting in the reliable detection of single copy varia-
tions on BAC array CGH. This method allows the detection of
specific genetic alterations in small neoplastic lesions, includ-
ing tumor biopsies obtained by non-surgical sampling methods
like endoscopies, and in clinically relevant subpopulations of
tumor cells, e.g. invading fronts of tumors. The significance of
the capability to detect single-copy alterations in tissue sam-
ples consisting of only a few thousand cells, lies in the greatly
expanded potential for discovery of novel genetic alterations
limited to small clonal patches in tumors, or present in small
preneoplastic lesions, as demonstrated here by the detection of
the subchromosomal 5q deletion in a FAP-derived adenoma-
tous polyp by combined LCM-array CGH analysis. These
features will facilitate the identification of novel oncogenes
or tumor suppressors mapping to regions of gene gain or loss
(6,46). An additional application in medical genetics is the
detection of copy-number changes in DNA derived from
buccal swaps for diagnosis of congenital chromosomal
abnormalities, such as microdeletions and duplications, and
unbalanced chromosomal translocations.
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